Key Metrics of Amon-Ra Impex Private Limited
About Amon-Ra Impex Private Limited
Company details
Company summary
Entity details
Compliance
Industry classification
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit ratings
WatchIssuer not cooperating with ICRA (rating based on limited information)
Rating history
Rating actions
| Date | Agency | Action | Long term | Short term | Outlook | Rated amount | Rationale |
|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | ICRA | Non-cooperating | B+ | A4 | Stable | ₹20.0 Cr | View |
| 14 Aug 2026 | CARE | Non-cooperating | B- | A4 | Stable | ₹5.50 Cr | View |
| 22 Jul 2025 | CARE | Non-cooperating | B- | A4 | Stable | ₹5.50 Cr | View |
| 03 Jul 2024 | CARE | Non-cooperating | B- | A4 | Stable | ₹5.50 Cr | View |
| 08 May 2023 | CARE | Non-cooperating | B- | A4 | Stable | ₹5.50 Cr | View |
| 09 May 2022 | CARE | Non-cooperating | B- | A4 | Stable | ₹5.50 Cr | View |
| 18 Feb 2021 | CARE | Non-cooperating (from B) | B- | A4 | Stable | ₹11.0 Cr | View |
| 04 May 2020 | CARE | Reaffirmed | B | A4 | Stable | ₹5.50 Cr | View |
| 14 May 2019 | CARE | Reaffirmed (from B+) | B | A4 | Stable | ₹5.50 Cr | View |
| 03 Apr 2019 | CARE | Non-cooperating | B+ | A4 | Stable | ₹7.75 Cr | View |
Credit strengths (CARE, Feb 2021)
+ Analytical Approach: Standalone
Applicable criteria Policy in respect of Non-cooperation by issuer CARE’s Policy on Default Recognition Criteria on assigning outlook and credit watch to Credit Ratings Rating Methodology - Wholesale Trading Criteria for Short Term Instruments Financial ratios – Non-Financial Sector
+ Brief Financials (Rs. crore) FY18 (A) FY19 (A)
Total operating income 8.53 6.90 PBILDT -0.01 -0.14 PAT -0.12 -0.24 Overall gearing (times) 0.83 0.78 Interest coverage (times) NEG NEG A: Audited; NEG: Negative Status of non-cooperation with previous CRA: Nil
+ Total operating income 8.53 6.90
PBILDT -0.01 -0.14 PAT -0.12 -0.24 Overall gearing (times) 0.83 0.78 Interest coverage (times) NEG NEG A: Audited; NEG: Negative Status of non-cooperation with previous CRA: Nil Any other information: Not Applicable
+ CARE B-; Stable; ISSUER NOT
Fund-based - LT-Cash - - - 0.50 COOPERATING* Credit CARE A4; ISSUER NOT Non-fund-based - ST- - - - 5.00 COOPERATING* Letter of credit
+ Instrument/Bank
No. Outstanding assigned Rating(s) assigned assigned assigned Facilities (Rs. crore) in 2020- in 2019-2020 in 2018- in 2017- 2021 2019 2018 1)CARE B; Stable (14-May-19) 1)CARE B; 1)CARE
+ Name of the Instrument Complexity Level
No. 1. Fund-based - LT-Cash Credit Simple 2. Non-fund-based - ST-Letter of credit Simple Note on complexity levels of the rated instrument: CARE has classified instruments rated by it on the basis of complexity. This classification is available at www.careratings.com. Investors/market intermediaries/regulators or others are welcome to write to care@careratings.com for any clarifications. 3 CARE Ratings Limited
Credit challenges
—
Could lead to an upgrade
Increase in the scale of operations with total operating income exceeding Rs.15 crore and tangible networth base exceeding Rs.5 crore on a sustained basis. Improvement in profit margins with PBILDT margin exceeding 2 -3% and PAT margin exceeding breakeven l evel on a sustained basis. Improvement in the debt coverage indicators with interest coverage exceeding 1.5 -2 times on a sustained basis Improvement in
Could lead to a downgrade
Deterioration in the capital structure with overall gearing exceeding unity level on a sustained basis
Agency-reported financials (ICRA, 21 Aug 2026)
| Metric | FY2024 | FY2025 |
|---|---|---|
| Operating income | ₹3.11 Cr | ₹2.20 Cr |
| PAT | ₹-0.39 Cr | ₹-0.40 Cr |
| OPBDITA/OI | -10.3% | -17.2% |
| PAT/OI | -12.5% | -18.7% |
| Total debt/OPBDITA (times) | -3.21× | -2.70× |
| Interest coverage (times) | -7.54× | -24.70× |
| Revenue growth (YoY) | — | −29.3% |
| EBITDA (margin × income) | ₹-0.32 Cr | ₹-0.38 Cr |
| Implied total debt (debt/EBITDA × EBITDA) | — | — |
| Implied interest cost (EBITDA ÷ coverage) | — | — |
Borrowings & rated debt
Rated limits over time
Facility mix
Rated facilities
| Facility | Type | Previous | Current | Change | Rating | Action | Agency |
|---|---|---|---|---|---|---|---|
| Long Term-Fund ISSUER NOT Based-Cash continues to remain | Working capital & bank lines | ₹50.0 L | ₹50.0 L | 0.0% | B+ (Stable) | Other | ICRA |
| Credit under ‘ ’ Short Term-Non Fund Based-continues to remain under ‘Issuer Not | Non-fund based limits | ₹7.83 Cr | ₹7.83 Cr | 0.0% | A4 | Non-cooperating | ICRA |
| Others ’ Long Term/Short ISSUER NOT Term-ISSUER NOT Unallocated continues to remain Limits under ‘ ’ | Working capital & bank lines | ₹11.7 Cr | ₹11.7 Cr | 0.0% | B+ / A4 (Stable) | Non-cooperating | ICRA |
CARE ratings on record (checked 01 Nov 2026)
| Instrument | Amount | Rating |
|---|---|---|
| Cash Credit | ₹50.0 L | CARE B-; Stable; ISSUER NOT COOPERATING* |
| Letter of credit | ₹5.00 Cr | CARE A4; ISSUER NOT COOPERATING* |
Credit assessment · Manufacturing
Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2024-25
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Not cooperating since 14 Aug 2026 (2 months) |
| Credit enhancement | None – standalone rating |
| Next action stable or better (model) | 31% |
| Information on file | 44% · missing: Audited financial statements (last 18 months), Debt obligations and repayment schedule, Capex / investment plans, Auditor details, Shareholding pattern |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Borrowing & funding lifecycle
- Credit outlook model: 31% chance the next rating action is stable or better
- Current rating B+ (below investment grade)
- Interest coverage -24.7×
- ₹11.67 cr of rated limits not yet tied to a lender
- Issuer not cooperating with the rating agency
Rated limits by facility
Timeline
From the report
Moreover, free cash and bank balance was Rs.0.31 crore as on March 31, 2018 (vis-à-vis Rs.0.23 crore as on March 31, 2017).
From the report
Comfortable capital structure: During FY18, the capital structure of the ARIPL has improved and stood at 0.35 times (vis- à-vis 0.81 times as on March 31, 2017) on account of repayment of term loans and unsecured loans as on balance sheet date.
Lender names, bank charges and audited borrowings are part of Premium.
Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.
Registered office and contact
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.